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Disease classification in rheumatology is a
matter of debate, in paediatrics between
International League Against Rheumatism
(ILAR) classification ‘pros and cons’, as well
as between paediatric and adult rheumatolo-
gists. Indeed, there is no consensus yet about
how we should name the disease of adults
with juvenile idiopathic arthritis ( JIA) in
childhood. The non-concordance of adult
and paediatric classifications for chronic
inflammatory rheumatic diseases is confusing
for caregivers, and above all for our patients.
Will they be ‘lost in transition’, as phrased by
McDonagh and Viner,1 when their disease
stays the same, but gets a new name? Will
their treatment be modified according to
this new name and the corresponding
recommendations for adult disease manage-
ment? Yes, it is definitely time to think about
a thorough modification of the ILAR cat-
egories of childhood chronic arthritis.2
The ILAR agreed on a classification that
comprises all types of idiopathic arthritis in
children under the umbrella term of JIA,
subdivided into seven categories comprising
the systemic, oligoarticular, rheumatoid factor
(RF)-negative polyarticular, RF-positive polyarti-
cular, juvenile psoriatic arthritis ( jPsA),
enthesitis-related arthritis (ERA) and the undif-
ferentiated form.3 This was the first time that
Europeans and Americans agreed to speak the
same language. However, since launched, the
ILAR classification has been regularly criti-
cised.4–6 It was revised in 2001, and the
reduced emphasis on heredity resulted in a sig-
nificant decrease in the rates of children with
undifferentiated arthritis.7 Calls for further
modifications are nevertheless still numerous.
Martini8 recognised that dividing patients
into groups according to the number of joints
involved at disease onset (oligoarticular/poly-
articular JIA) was not gathering homogeneous
categories; others claimed that strict exclusion
criteria of the present classification excluded
many authentic juvenile spondyloarthritides
from the ERA category,9 10 the same for the
jPsA category,11 12 and even the RF-positive
polyarticular category.13 The undifferentiated
arthritis group varies markedly in frequency
in different reports, because it depends on
thorough work-up on heredity and other
exclusion criteria.14 15 Contrary to the inten-
tions of the ILAR, the undifferentiated group
in follow-up tends to increase instead of
decrease over time.15
A new proposal is emerging from Martini
and colleagues to define a group composed
of young children ≤6 years of age with arth-
ritis and presence of antinuclear antibodies
(ANA). Indeed, two important papers from
their team showed that the clinical charac-
teristics of ANA-positive young children
during the first 2 years after disease onset
were very similar despite being classified into
different ILAR categories, that is, RF-negative
polyarticular, oligoarticular (persistent and
extended), jPsA and undifferentiated arth-
ritis, proving at the same time how heteroge-
neous these categories are.16 17 However,
there are several concerns.
First, we have pointed out that the ANA
immunofluorescence test is operator-
dependent and still not consensual in terms
of threshold of positivity in different labora-
tories worldwide, even though the aforemen-
tioned studies define ANA positivity as two
positive immunofluorescence tests at a titre of
≥1/160 on Human Epithelial type 2 (HEp-2)
cells at least 3 months apart.16 17 Second,
ANA in JIA still have no identified biological
target, and therefore no clear link to aeti-
ology, pathophysiology or treatment option.18
Most importantly, prospective long-term
follow-up of young children with ANA-positive
JIA from different cohorts and geographical
regions is still lacking. Therefore, ANA should
not in our opinion be a classification deter-
minant until more standardisation and evi-
dence for relevance in treatment, disease
course or outcome is available.
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(SpA) in children is mutually exclusive in the ILAR clas-
sification, jPsA being restrictive compared with the classi-
fication of psoriatic arthritis (CASPAR) criteria. Recent
findings of histologically inflamed entheses in dactylitic
fingers, suggests that dactylitis and peripheral arthritic
involvement often seen in young girls and enthesitis and
axial involvement in older boys may be different mani-
festations of the same disease process.19 New knowledge
has emerged on the role of certain interleukins, and
subsequent targeted therapies are developed for PsA in
adults.20 Too strict exclusion criteria for jPsA and ERA
may exclude some children and adolescents from access
to these treatments, and should therefore be reconsid-
ered in a new ILAR classification.
In the September issue 2016 of RMD Open, an elegant
article on rheumatic disease classification is presented
by Oliveira-Ramos et al14 from Portugal. These authors
describe the classification outcome of 426 patients with
JIA followed for a mean of 22.5 years into adulthood
and reclassified according to the adult classification cri-
teria of chronic inflammatory rheumatic diseases (2010
American College of Rheumatology (ACR)/ European
League Against Rheumatism (EULAR) for rheumatoid
arthritis (RA), 1984 modified New York criteria for anky-
losing spondylitis, CASPAR criteria for PsA, adult Still’s
disease, unclassifiable patients (undifferentiated arth-
ritis)). The table is drawn from their data (table 1).
The left part of the table confirms what many paediat-
ric rheumatologists believe: the systemic, the RF-positive
polyarticular JIA, the ERA and the jPsA categories have
their adult counterpart. Then, do we need different
words to name them?2 Although the classifications of
adult RA, PsA and SpA also include heterogeneous phe-
notypes, their treatment strategies are rapidly evolving,
and the therapies constantly evaluated. Harmonising the
name and the criteria of the disease for the systemic,
the RF-positive polyarticular JIA, ERA and jPsA categor-
ies between childhood and adult units of care, may allow
smoother transfer, and importantly, that they receive the
targeted treatments at the right time.
In the right part of the table, the evolution of the
RF-negative polyarticular and the oligoarticular groups
are shown. Around 15% of the patients classified to have
oligoarthritis (persistent and extended) fit SpA classifi-
cation; almost 40% of the oligoextended and 60% of the
RF-negative polyarticular categories fit the criteria for
RA, and 24–60% of the oligoarticular categories and
RF-negative polyarticular are classified as undifferenti-
ated chronic inflammatory arthritis. Of course, informa-
tion on ANA status, and detailed clinical presentation at
onset in relation to specific outcome categories (RA/
SpA/PsA/undifferentiated) would be particularly inter-
esting to look at.
Modification of the JIA classification should be based
on knowledge from prospective cohorts and ongoing
international registries extending far beyond 10 years
follow-up in order to assess adult outcome. In addition,
research on genetics and novel disease biomarkers will
hopefully help defining more relevant disease categor-
ies. In fact, a recent report from a large consortium on
JIA genetics shows that the JIA categories potentially
have adult counterparts: the strong associations between
RF-positive polyarthritis and specific human leukocyte
antigen (HLA) DRB1* alleles are seen both in children
and adults.21 Interestingly, the combined oligoarthritis
and RF-negative polyarthritis categories share the same
HLA association with adult seronegative RA.21
So how are Oliveira-Ramos et al’s results clinically rele-
vant to the up-coming change in ILAR classification? For
the caregiver, the nomenclature and classification guide
treatment and follow-up strategies. For the patient,
receiving the most effective treatment is the main object-
ive. We know that JIA categories change over time in
children and may also change in adults, when they are
followed closely for features of psoriasis, enthesitis or
spondyloarthropathy, or when adult rheumatologists
rename the juvenile rheumatic disease. The work of
Oliveira-Ramos et al is of crucial importance in this time
of redefining JIA classification. Further studies of
genetic and early clinical characteristics of JIA in chil-
dren, in order to collect RA, SpA or PsA specific traits,
Table 1 Paediatric JIA categories reclassified according to
the adult classification criteria of chronic inflammatory
























































jPsA (13) PsA (12) 92.3%
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AS, ankylosing spondylitis; ASD, adult Still’s disease; EnterA:
enteropathic arthritis; ERA, Enthesitis-Related Arthritis; jPsA :
juvenile Psoriatic Arthritis; Persist/Extend Oligo, persistent/
extended oligoarticular JIA; PsA, psoriatic arthritis; RA,
rheumatoid arthritis; RFneg Poly JIA, rheumatoid factor negative
polyarticular JIA; RFpos Poly JIA, rheumatoid factor positive
polyarticular JIA; Syst JIA, systemic JIA; USpA, undifferentiated
spondyloarthritis; Undiff, undifferentiated arthritis.
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may be a way to unify the paediatric and adult classifica-
tions of rheumatic diseases, for the entire benefit of our
children and adolescents. We hope our patients can
finally recognise themselves as having the same disease
from childhood to adulthood.
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